Abstract
The first inborn error of metabolism to be recognized was alcaptonuria, described by Garrod in 19081. He developed the concept that some diseases occur because an enzyme which controls a single metabolic step is entirely absent or has a greatly reduced activity. More than 330 such disorders have now been described2, more than 30 of which are lysosomal storage diseases.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Garrod, A. E. (1908). Inborn errors of metabolism. Croonian Lectures. Lancet, 2, 1
Stanbury, J. B., Wyngaarden, J. B. and Fredrickson, D. S. (1978). The Metabolic Basis of Inherited Disease, p. 14. (NewYork: McGraw Hill)
Neuwelt, E., Stumpf, D., Austin, J. and Kohler, P. (1971). A monospecific antibody to human sulphatase A. Biochim. Biophys. Acta, 236, 333
Mersmann, G. and Buddecke, E. (1977). Evidence from mannosidosis fibroblasts cross reacting with anti-acidic α-mannosidase antibodies. FEBS Lett., 73, 123
Bell, C. E. Jr., Sly, W. S. and Brot, F. E. (1977). Human β-glucuronidase deficiency mucopolysaccharidosis: identification of cross-reactive antigen in cultured fibroblasts of deficient patients by primary enzyme immunoassay, J. Clin. Invest., 59, 97
Di Ferrante, N., Nichols, B., Donnelly, P. V., Neri, G., Hrgovcic, R. and Berglund, R. K. (1971). Induced degradation of glycosaminoglycans in Hurler’s and Hunter’s syndromes by plasma infusion. Proc. Natl. Acad. Sci. USA, 68, 303
Dean, M. F., Benson, P. F. and Muir, H. (1973) Mobilisation of glycosaminoglycans by plasma infusions in mucopolysaccharidosis type III - Two types of response. Nature (London) New Biol., 243, 143.
Dean, M. F. Benson, P. F. and Muir, H. (1975). Differing patterns of glycosaminoglycan mobilisation in Sanfilippo and Hunter Syndromes following infusion of normal plasma. In Proceedings of the 3rd International Congress for the Scientific Study of Mental Deficiency, p. 270. (The Hague: International Association for the Scientific Study of Mental Deficiency)
Knudson, A. G., Di Ferrante, N. and Curtis, J. E. (1971). Effect of leucocyte transfusion in a child with type II mucopolysaccharidosis. Proc. Natl. Acad. Sci. USA, 68, 1738
Moser, H. W., O’Brien, J. S., Atkins, L., Fuller, T. C., Keiman, A., Janowska, S., Russell, P. F., Bartsocas, C. S., Cosimi, B. and Dulaney, J. T. (1974). Infusion of normal HLA identical lymphocytes in Sanfilippo disease type B. Arch. Neurol., 31, 329
Brady, R. O., Tallman, J. F., Johnson, W. G., Gal, A. E., Leahy, W. R., Quick, J. M. and Dekaban, A. S. (1973). Replacement thrapy for inherited enzyme deficiency. Use of purified ceramidetrihexosidase in Fabry’s disease. N. Engl. J. Med., 289, 9
Gregoriadis, G. (1979). Liposomes. In Gregoriadis, G. (ed.) Drug Carriers in Biology and Medicine, pp. 287-341 (London: Academic Press)
Clarke, J. T. R., Guttman, R. D., Wolfe, L. S., Beaudoin, J. G. and Morehouse, D. D, (1972). Enzyme replacement therapy by renal allotransplantation in Fabry’s disease. N. Engl. J. Med., 287, 1215
Philippart, M., Franklin, S. S. and Gordon, A. (1972). Reversal of an inborn sphingolipidosis (Fabry’s disease) by kidney transplantation. Ann. Int. Med., 77, 195
Dean, M. F., Muir, H. Benson, P. F., Button, L. R. Batchelor, J. P. and Bewick, M. (1975). Increased breakdown of glycosaminoglycans and increased appearance of corrective enzyme after skin transplants in Hunter Syndrome. Nature (London), 257, 609
Dean, M. F., Stevens, R. L. Muir, H., Benson, P. F., Button L R Anderson, R. L., Boylston, A. and Mowbray, J. (1979). Enzyme replacement therapy by fibroblast transplantation. Long-term biochemical study in 3 cases of Hunter’s Syndrome. J. Clin. Invest., 63, 138
Dean, M. F., Muir, H., Benson, P. F., Button, L. R. (1980). Enzyme replacement therapy in the Mucopolysaccharidoses by fibroblast transplantation. In Birth Defects. Original Article Series Vol. XVI No 1, p 445 (USA: March of Dimes Birth Defects Foundation)
Gibbs, D. A., Spellacy, E., Roberts, A. E. and Watts, R. W. E. (1980). The treatment of lysosomal storage diseases by fibroblast transplantation: Some preliminary observations. In Birth Defects: Original Article Series Vol. XVI, No. 1, p. 457 (USA: March of Dimes Birth Defects Foundation)
von Figura, K., and Kresse, H. (1974). Quantitative aspects of pinocytosis and the intracellular fate of N-acetyl-α-D-glucosaminidase in Sanfilippo B fibroblasts. J. Clin. Invest., 53, 85
Sando, G. N. and Neufeld, E. F. (1977). Recognition and receptor mediated uptake of a lysosomal enzyme, α-L-iduronidase by cultured human fibroblasts. Cell, 12, 619
Ullrich. K., Mersmann, G., Weber, E. and von Figura, K. (1978). Evidence lor lysosomal enzyme recognition by human fibroblasts via a phosphorylated carbohydrate moiety. Biochem. J., 170, 643
Rome, L. H., Garvin, A. J., Allietta, M. M. and Neufeld, E. F. (1979). Two species of lysosomal organelles in cultured human fibroblasts. Cell, 17, 143
Dean, M. F., Benson, P. F. and Muir, H. (1975). The effect of dextran infusions on glycosaminoglycan excretion in the Sanfilippo Syndrome. Devel. Med. Child. Neurol., 17, 47
O’Brien, J. S., Miller, A. L., Loverde, A. W. and Veath, M. L. (1973). Sanfilippo disease type B: Enzyme replacement and metabolic correction in cultured fibroblasts. Science, 187, 753
Barton, R W. and Neufeld, E. F. (1971). The Hurler corrective factor: Purification and some properties. J. Biol. Chem 246, 7773
Kresse, H. and Neufeld, E. F. (1972). The Sanfilippo A corrective factor: Purification and mode of action. J. Biol Chem., 247, 2164
Cantz, M., Chrambach, A., Bach, G. and Neufeld, E. F. (1972). The Hunter corrective factor: Purification and preliminary characterisation. J. Biol. Chem., 247, 5456
Bach, G. and Liebmann-Eisenberg, A. (1979) Intracellular localization of exogenous β-glucuronidase in cultured skin fibroblasts. Eur. J. Biochem., 96, 613
Fratantoni, J C., Hall, C. W. and Neufeld, E. F. (1968). Hurler and Hunter Syndromes. Mutual corrections of the defect in cultured fibroblasts. Science (Wash.), 162, 500
Fratantoni, J. C., Hall, C. W. and Neufeld, E. F. (1969). The defect in Hurler and Hunter Syndromes. II Deficiency of specific factors involved in mucopolysaccharide degradation. Proc. Natl. Acad. Sci. USA 64, 360
Rome, L. H., Garvin, A. J., Allietta, M. M. and Neufeld, E. F (1979) Two species of lysosomal organelles in cultured human fibroblasts Cell 17, 143
McKusick, V. A. (1972). Heritable Disorders of Connective tissues, p. 556. (St. Louis: Mosby)
Kresse, H. (1973). Mucopolysaccharidosis IIIA (Sanfilippo A Disease): A deficiency of a heparin sulphamidase in skin fibroblasts and leucocytes. Biochem. Biophys. Res. Commun., 54, 1111
Bach, G., Eisenberg, F. Jr., Cantz, M. and Neufeld, E. F (1973). The defect in the Hunter Syndrome: Deficiency of sulphoiduronate sulphatase. Proc. Natl. Acad. SCi. USA, 70, 2134
Bitter, T. and Muir, H. (1962). A modified uronic acid carbazole reaction. Anal. Biochem., 4, 330
Kraan, J. and Muir, H. (1957). The determination of glucosamine. Biochem. J., 66, 55
Ginsberg, L. C. and Di Ferrante, N. (1977). Sensitive method for the determination of ester sulphate in biological systems. Biochem. Med., 17, 80
Lagunoff, D. and Warren, G. (1962). Determination of 2-deoxy-2-sulph-aminohexose content of mucopolysaccharides. Arch. Biochem. Biophys., 99, 396
Lim, T. W., Leder, I. G., Bach, G. and Neufeld, E. F. (1974). Assay for iduronate sulphatase. Carbohydr. Res., 37, 103
Liebaers, I. and Neufeld, E. F. (1976). Iduronate sulphatase activity in serum, lymphocytes and fibroblasts - simplified diagnosis of the Hunter Syndrome, Pediatr. Res., 10, 733
Bach, G., Friedmann, R., Weismann, B. and Neufeld, E. F. (1972). The defect in Hurler and Scheie Syndromes. Deficiency of α-L-iduronidase. Proc. Natl. Acad. SCi. USA, 69, 2084
Kaplan, A., Achord, D. T. and Sly, W. S. (1977). Phosphohexosyl components of a lysosomal enzyme are recognised by pinocytosis receptors on human fibroblasts. Proc. Natl. Acad. Sci. USA., 74, 2026
Sando, G. N. and Neufeld, E. F. (1977). Recognition and receptor mediated uptake of a lysosomal enzyme, α-L-iduronidase by cultured human fibroblasts. Cell, 12, 619
Feder, N. (1976). Solitary cells and enzyme exchange in tetraparental mice. Nature (London), 263, 66
Jolly, R. D., Thompson, K. G., Murphy, C. E., Manktelow, B. W., Bruere, A. M. and Winchester, B. G. (1976). Enzyme replacement therapy-an experiment in nature in a clinical mannosidosis calf. Pediatr. Res., 10, 219
Kihara, H., Porter, M. and Fluharty, A. (1973). In Birth Defects, Original Article Series, Vol. 9, pp. 19-26, National Foundation March of Dimes. (New York: Williams and Wilkins)
Mersmann, G. and Buddecke, E. (1976). Storage of Mannose containing material in cultured human mannosidosis cells and metabolic correction by pig kidney α-mannosidase. Hoppe-Seyler’s Z. Physiol. Chem., 357, 641
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 The Society for the Study of Inborn Errors of Metabolism
About this chapter
Cite this chapter
Dean, M.F., Muir, H., Benson, P.F., Button, L.R. (1982). Enzyme substitution by fibroblast transplantation. In: Cockburn, F., Gitzelmann, R. (eds) Inborn Errors of Metabolism in Humans. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-7325-1_8
Download citation
DOI: https://doi.org/10.1007/978-94-009-7325-1_8
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-009-7327-5
Online ISBN: 978-94-009-7325-1
eBook Packages: Springer Book Archive